Clinical trial NCT02803476 - References

Insulin Resistance — Is There Association Between Vitamin D Levels And Insulin Resistance In Polycystic Ovary Syndrome?

Citation(s)

•   Adams JS, Hewison M
  Update in vitamin D. J Clin Endocrinol Metab. 2010 Feb;95(2):471-8. doi: 10.1210/jc.2009-1773. Review.
•   Ardabili HR, Gargari BP, Farzadi L
  Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res. 2012 Mar;32(3):195-201. doi: 10.1016/j.nutres.2012.02.001.
•   Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO
  The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004 Jun;89(6):2745-9.
•   Barber TM, Dimitriadis GK, Andreou A, Franks S
  Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance. Clin Med (Lond). 2016 Jun;16(3):262-6. doi: 10.7861/clinmedicine.16-3-262.
•   Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ
  Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995 Oct;38(10):1239-45.
•   Campbell MJ, Julious SA, Altman DG
  Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ. 1995 Oct 28;311(7013):1145-8. Review. Erratum in: BMJ 1996 Jan 13;312(7023):96.
•   Carmina E
  Genetic and environmental aspect of polycystic ovary syndrome. J Endocrinol Invest. 2003 Nov;26(11):1151-9. Review.
•   Cook JA, Hislop J, Adewuyi TE, Harrild K, Altman DG, Ramsay CR, Fraser C, Buckley B, Fayers P, Harvey I, Briggs AH, Norrie JD, Fergusson D, Ford I, Vale LD
  Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Diffe
•   Dunaif A
  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997 Dec;18(6):774-800. Review.
•   Fox N, Mathers N
  Empowering research: statistical power in general practice research. Fam Pract. 1997 Aug;14(4):324-9. Review.
•   Franks S, Stark J, Hardy K
  Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008 Jul-Aug;14(4):367-78. doi: 10.1093/humupd/dmn015. Epub 2008 May 22. Review. Erratum in: Hum Reprod Update. 2008 Sep-Oct;14(5):539.
•   Gluckman PD, Hanson MA, Cooper C, Thornburg KL
  Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008 Jul 3;359(1):61-73. doi: 10.1056/NEJMra0708473. Review.
•   Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, Kimmig R, Mann K, Janssen OE
  Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabe
•   He C, Lin Z, Robb SW, Ezeamama AE
  Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis. Nutrients. 2015 Jun 8;7(6):4555-77. doi: 10.3390/nu7064555. Review.
•   Hollis BW
  Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. Endocrinol Metab Clin North Am. 2010 Jun;39(2):271-86, table of contents. doi: 10.1016/j.ecl.2010.02.012. Review.
•   Johnstone EB, Rosen MP, Neril R, Trevithick D, Sternfeld B, Murphy R, Addauan-Andersen C, McConnell D, Pera RR, Cedars MI
  The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endoc
•   Kumar S, Davies M, Zakaria Y, Mawer EB, Gordon C, Olukoga AO, Boulton AJ
  Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad Med J. 1994 Jun;70(824):440-3.
•   Lin MW, Wu MH
  The role of vitamin D in polycystic ovary syndrome. Indian J Med Res. 2015 Sep;142(3):238-40. doi: 10.4103/0971-5916.166527.
•   Lobo RA, Carmina E
  The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med. 2000 Jun 20;132(12):989-93. Review.
•   Nestler JE, Reilly ER, Cheang KI, Bachmann LM, Downs RW Jr
  A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome. Trans Am Clin Climatol Assoc. 2012;123:209-19; discussion 219-
•   Nishida C, Ko GT, Kumanyika S
  Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr. 2010 Jan;64(1):2-5. doi: 10.1038/ejcn.2009.139. Epu
•   Orwoll E, Riddle M, Prince M
  Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 1994 May;59(5):1083-7.
•   Pal L, Berry A, Coraluzzi L, Kustan E, Danton C, Shaw J, Taylor H
  Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecol Endocrinol. 2012 Dec;28(12):965-8. doi: 10.3109/09513590.2012.696753. Epub 201
•   Raja-Khan N, Shah J, Stetter CM, Lott ME, Kunselman AR, Dodson WC, Legro RS
  High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial. Fertil Steril. 2014 Jun;101(6):1740-6.
•   Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, Handunnetthi L, Handel AE, Disanto G, Orton SM, Watson CT, Morahan JM, Giovannoni G, Ponting CP, Ebers GC, Knight JC
  A ChIP-seq defined genome-wide map of vitamin D receptor binding
•   Rosenfield RL
  Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab. 2007 Mar;92(3):787-96. Epub 2006 Dec 19. Review.
•   Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group
  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004 Jan;19(1):41-7. Review.
•   Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G, Tuncel E, Erturk E, Imamoglu S
  The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest. 2010 Apr;33(4):234-8. doi: 10.3275/6560. Epub 2009 Oct 9.
•   Thomson RL, Spedding S, Buckley JD
  Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012 Sep;77(3):343-50. doi: 10.1111/j.1365-2265.2012.04434.x. Review.
•   Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR, Obermayer-Pietsch B
  Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol. 2009 Oct;161(4):575-82. doi: 10.1530/EJE-09-0432. Epub 2009
•   Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG, Kamaci M
  Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet. 2009 Oct;280(4):559-63. doi: 10.1007/s00404-009-0958-7. Epub 2009 Feb 13.

Is There An Association Between Vitamin D Levels And Insulin Resistance In Polycystic Ovary Syndrome?

Details for clinical trial NCT02803476